Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

NEWS ABOUT >

Biotechnology

Clean Rooms

Clinical Trials

Consultants

Digitalization

Drug Discovery & Development

Engineering

Global Pharma

Industrial talks

Ingredients

Lab Equipment

Logistics & Distribution

Manufacturing

Market

Outsourcing

Packaging

Quality / GMP

Regulation

Safety

Last edition

All magazines
Subscribe to our magazine

News about " ACL injury"

Tempus Wins FDA Approval for xT CDx, Expanding Solid Tumor Testing Portfolio

Tempus has received US FDA approval for its tumor-only xT CDx, becoming the first laboratory with companion diagnostic approval for both tumor-only and tumor-normal genomic profiling.

ACL Injury | 30/05/2026 | By News Bureau | 123

FDA Grants 510(k) Clearance for Updated BEAR Implant Label, Showing Reduced Risk of Post-Traumatic Osteoarthritis After ACL Injury

Miach Orthopaedics’ BEAR Implant becomes the first sports medicine device to carry an FDA-cleared claim for lowering long-term osteoarthritis risk compared with traditional ACL reconstruction.

ACL Injury | 16/01/2026 | By News Bureau | 474

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members